Description
5-Methyltetrahydrofolic Acid is the racemic form of Levomefolic acid.
| Product Unit Size | Cost | Quantity | Stock |
|---|
5-Methyltetrahydrofolic Acid is the racemic form of Levomefolic acid.
| Cas No. | 134-35-0 |
|---|---|
| Purity | ≥98% |
| Formula | C20H25N7O6 |
| Formula Wt. | 459.45 |
| Chemical Name | 5-Methyl-5,6,7,8-tetrahydrofolic Acid |
| IUPAC Name | (2S)-2-[[4-[(2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
| Synonym | 5-methyl THF, Prefolic A, N-Methyltetrahydrofolic Acid, N-[4-[[(2-Amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid |
| Melting Point | 250°C |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Bumetanide impurity
Found in Evodia rutaecarpa; potential cAMP, 3β...
Akt inhibitor.
Nucleoside (deoxyadenosine) analog found in Co...
Cathepsin K inhibitor.
Selective inhibitor of cytochrome P450 1B1 (CYP...
p53 inhibitor
EGFR inhibitor.
Selective inhibitor of LRRK2.
Endogenous neurotransmitter; GABA agonist.
NPC1L1 inhibitor.
VEGFR2, PDGFR, FGFR2 inhibitor.
Prodrug
Proteasome inhibitor.
Endogenous peptide hormone inolved in gastric e...
RIP1 inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Aminothiol, CoA component; ulcer inducer.
PI3K and PDK1 inhibitor.
Macrolide; protein synthesis inhibitor.